Back

Myocardial bridging in hypertrophic cardiomyopathy: prevalence, characteristics, and clinical implications

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 8 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ines Ferreira Neves

Centro Hospitalar Universitario de Lisboa Central, E.P.E., Lisboa (Portugal)

5 More presentations in this session

Presentation thumbnail
One gene, the same mutation, different natural histories: the diverse odyssey of four families with hypertrophic cardiomyopathy
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
QRS-T angle is associated with sudden cardiac death risk in patients with hypertrophic cardiomyopathy
Doctor H. Chung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Exercise echocardiography to evaluate the diastolic function in hypertrophic cardiomyopathy
Doctor D. Faro (Catania, IT)
Abstract Slides Video
Presentation thumbnail
Clinical profile and outcomes of patients with hypertrophic cardiomyopathy associated with mutations in the MYH7 gene: a long longitudinal follow up study
Doctor C. Gregorio (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Sarcomere-negative hypertrophic cardiomyopathy: clinical characteristics, management, and outcomes
Doctor I. Martins Moreira (Vila Real, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocardial disease - clinical 8

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy and coronary artery disease: prevalence, characteristics, and implications in the context of evolving physical exercise recommendations
thumbnail
Congress Presentation
Nationwide trends in utilization and safety of ventricular arrythmia ablation in patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources